Literature DB >> 25435917

Management of priapism: an update for clinicians.

Helen R Levey1, Robert L Segal2, Trinity J Bivalacqua3.   

Abstract

Priapism is a prolonged erection that persists beyond or is unrelated to sexual stimulation. It is associated with significant morbidity: psychological, socioeconomic, and physical, including pain and potentially irreversible compromise of erectile function. There are three major types of priapism: ischemic, nonischemic, and stuttering. Establishing the type of priapism is paramount to safely and effectively treating these episodes. Ischemic priapism represents a urological emergency. Its treatment may involve aspiration/irrigation with sympathomimetic injections, surgical shunts, and as a last resort, penile prosthesis implantation. Nonischemic priapism results from continuous flow of arterial blood into the penis, most commonly related to penile trauma. This is not an emergency and may be managed conservatively initially, as most of these episodes are self-limiting. Stuttering priapism involves recurrent self-limiting episodes of ischemic priapism. The primary goal of therapy is prevention, but acute episodes should be managed in accordance with guidelines for ischemic priapism. In this paper we review the diagnosis and treatment of the three priapism variants, as well as discuss future targets of therapy and novel targets on the horizon.

Entities:  

Keywords:  guidelines; ischemic; non-ischemic; priapism; recurrent; stuttering

Year:  2014        PMID: 25435917      PMCID: PMC4236300          DOI: 10.1177/1756287214542096

Source DB:  PubMed          Journal:  Ther Adv Urol        ISSN: 1756-2872


  87 in total

1.  Androgen blockade for the treatment of high-flow priapism.

Authors:  Kuwong B Mwamukonda; Thomas Chi; Alan W Shindel; Tom F Lue
Journal:  J Sex Med       Date:  2010-04-26       Impact factor: 3.802

2.  Acidosis impairs rabbit trabecular smooth muscle contractility.

Authors:  I Saenz de Tejada; N N Kim; J T Daley; R Royai; J Hypolite; G A Broderick; F Garcia-Diaz; R Levin
Journal:  J Urol       Date:  1997-02       Impact factor: 7.450

3.  The use of high-resolution magnetic resonance imaging in the management of patients presenting with priapism.

Authors:  David J Ralph; Nigel C Borley; Clare Allen; Alex Kirkham; Alex Freeman; Suks Minhas; Asif Muneer
Journal:  BJU Int       Date:  2010-12       Impact factor: 5.588

4.  Daily phosphodiesterase type 5 inhibitor therapy as rescue for recurrent ischemic priapism after failed androgen ablation.

Authors:  Phillip M Pierorazio; Trinity J Bivalacqua; Arthur L Burnett
Journal:  J Androl       Date:  2010-12-02

5.  T-shaped shunt and intracavernous tunneling for prolonged ischemic priapism.

Authors:  William O Brant; Maurice M Garcia; Anthony J Bella; Tom Chi; Tom F Lue
Journal:  J Urol       Date:  2009-02-23       Impact factor: 7.450

6.  Priapism, its incidence and seasonal distribution in Finland.

Authors:  R V Kulmala; T A Lehtonen; T L Tammela
Journal:  Scand J Urol Nephrol       Date:  1995-03

7.  Oral ketoconazole for prevention of postoperative penile erection: a placebo controlled, randomized, double-blind trial.

Authors:  Brian J DeCastro; Raymond A Costabile; Leah P McMann; Andrew C Peterson
Journal:  J Urol       Date:  2008-03-18       Impact factor: 7.450

8.  The immediate insertion of a penile prosthesis for acute ischaemic priapism.

Authors:  David J Ralph; Giulio Garaffa; Asif Muneer; Alex Freeman; Rowland Rees; Andrew N Christopher; Sukbinder Minhas
Journal:  Eur Urol       Date:  2008-10-01       Impact factor: 20.096

9.  Sickle cell disease status and outcomes of African-American men presenting with priapism.

Authors:  Nelson Bennett; John Mulhall
Journal:  J Sex Med       Date:  2008-02-25       Impact factor: 3.802

Review 10.  Pathophysiology of priapism: dysregulatory erection physiology thesis.

Authors:  Arthur L Burnett
Journal:  J Urol       Date:  2003-07       Impact factor: 7.450

View more
  24 in total

1.  The effects of oxytocin on penile tissues in experimental priapism model in rats.

Authors:  Engin Kolukcu; Sahin Kilic; Bekir Suha Parlaktas; Fikret Erdemir; Velid Unsal; Dogan Atılgan; Nihat Uluocak
Journal:  Int Urol Nephrol       Date:  2018-12-04       Impact factor: 2.370

Review 2.  Metabolomic and molecular insights into sickle cell disease and innovative therapies.

Authors:  Morayo G Adebiyi; Jeanne M Manalo; Yang Xia
Journal:  Blood Adv       Date:  2019-04-23

3.  How I treat priapism.

Authors:  Uzoma A Anele; Brian V Le; Linda M S Resar; Arthur L Burnett
Journal:  Blood       Date:  2015-03-25       Impact factor: 22.113

Review 4.  Embolization Treatment of High-Flow Priapism.

Authors:  Kyung Rae Kim
Journal:  Semin Intervent Radiol       Date:  2016-09       Impact factor: 1.513

5.  Recurrent priapism in spinal cord injury: A case report.

Authors:  Engin Koyuncu; Özlem Taşoğlu; Ali Orhan; Sibel Özbudak Demir; Neşe Özgirgin
Journal:  J Spinal Cord Med       Date:  2019-05-10       Impact factor: 1.985

6.  Coronavirus disease 2019 (COVID-19) and priapism: An unexplored association.

Authors:  Dominic Mpumelelo Malinga; Abdullah E Laher; Jared McDowall; Ahmed Adam
Journal:  Curr Urol       Date:  2022-06-27

7.  Priapism in patients with hemolytic disorders: a nationwide retrospective cohort study.

Authors:  Stinne Tranekær; Dennis Lund Hansen; Bart J Biemond; Anne Lykke Sørensen; Andreas Glenthøj; Jesper Petersen; Henrik Frederiksen
Journal:  Ann Hematol       Date:  2021-06-16       Impact factor: 3.673

Review 8.  Malignant Priapism - What Do We Know About It?

Authors:  Dragos Marcu; Lucian Iorga; Dan Mischianu; Nicolae Bacalbasa; Irina Balescu; Ovidiu Bratu
Journal:  In Vivo       Date:  2020 Sep-Oct       Impact factor: 2.155

Review 9.  Clinical Management of Priapism: A Review.

Authors:  Kazuyoshi Shigehara; Mikio Namiki
Journal:  World J Mens Health       Date:  2016-04-30       Impact factor: 5.400

10.  Risk Factors for Surgical Shunting in a Large Cohort With Ischemic Priapism.

Authors:  Hanson Zhao; Kai Dallas; John Masterson; Eric Lo; Justin Houman; Carl Berdahl; Joshua Pevnick; Jennifer T Anger
Journal:  J Sex Med       Date:  2020-11-15       Impact factor: 3.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.